Viral membrane fusion von Harrison, Stephen C

Volltext

A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis von Newsome, Philip N, Buchholtz, Kristine, Cusi, Kenneth, Linder, Martin, Okanoue, Takeshi, Ratziu, Vlad, Sanyal, Arun J, Sejling, Anne-Sophie, Harrison, Stephen A

Volltext

NAFLD-related hepatocellular carcinoma: The growing challenge von Shah, Pir Ahmad, Patil, Rashmee, Harrison, Stephen A

Volltext

Viral membrane fusion von Harrison, Stephen C

Volltext

Pharmacotherapy for NASH: Current and emerging von Konerman, Monica A., Jones, Jacob C., Harrison, Stephen A.

Volltext

Challenges and opportunities in NASH drug development von Harrison, Stephen A., Allen, Alina M., Dubourg, Julie, Noureddin, Mazen, Alkhouri, Naim

Volltext

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases von Chalasani, Naga, Younossi, Zobair, Lavine, Joel E., Charlton, Michael, Cusi, Kenneth, Rinella, Mary, Harrison, Stephen A., Brunt, Elizabeth M., Sanyal, Arun J.

Volltext

From NAFLD to MAFLD: Implications of a Premature Change in Terminology von Younossi, Zobair M., Rinella, Mary E., Sanyal, Arun J., Harrison, Stephen A., Brunt, Elizabeth M., Goodman, Zachary, Cohen, David E., Loomba, Rohit

Volltext

Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes von Ahmed, Aijaz, Wong, Robert J, Harrison, Stephen A

Volltext

Structure of the MIND Complex Defines a Regulatory Focus for Yeast Kinetochore Assembly von Dimitrova, Yoana N., Jenni, Simon, Valverde, Roberto, Khin, Yadana, Harrison, Stephen C.

Volltext

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis von Harrison, Stephen A., Bedossa, Pierre, Guy, Cynthia D., Schattenberg, Jörn M., Loomba, Rohit, Taub, Rebecca, Labriola, Dominic, Moussa, Sam E., Neff, Guy W., Rinella, Mary E., Anstee, Quentin M., Abdelmalek, Manal F., Younossi, Zobair, Baum, Seth J., Francque, Sven, Charlton, Michael R., Newsome, Philip N., Lanthier, Nicolas, Schiefke, Ingolf, Mangia, Alessandra, Pericàs, Juan M., Patil, Rashmee, Sanyal, Arun J., Noureddin, Mazen, Bansal, Meena B., Alkhouri, Naim, Castera, Laurent, Rudraraju, Madhavi, Ratziu, Vlad

Volltext

Clinical Trial Landscape in NASH von Harrison, Stephen A., Loomba, Rohit, Dubourg, Julie, Ratziu, Vlad, Noureddin, Mazen

Volltext

A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH von Francque, Sven M, Bedossa, Pierre, Ratziu, Vlad, Anstee, Quentin M, Bugianesi, Elisabetta, Sanyal, Arun J, Loomba, Rohit, Harrison, Stephen A, Balabanska, Rozalina, Mateva, Lyudmila, Lanthier, Nicolas, Alkhouri, Naim, Moreno, Christophe, Schattenberg, Jörn M, Stefanova-Petrova, Diana, Vonghia, Luisa, Rouzier, Régine, Guillaume, Maeva, Hodge, Alexander, Romero-Gómez, Manuel, Huot-Marchand, Philippe, Baudin, Martine, Richard, Marie-Paule, Abitbol, Jean-Louis, Broqua, Pierre, Junien, Jean-Louis, Abdelmalek, Manal F

Volltext

Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial von Harrison, Stephen A., Taub, Rebecca, Neff, Guy W., Lucas, K. Jean, Labriola, Dominic, Moussa, Sam E., Alkhouri, Naim, Bashir, Mustafa R.

Volltext

Structure of the DASH/Dam1 complex shows its role at the yeast kinetochore-microtubule interface von Jenni, Simon, Harrison, Stephen C

Volltext

Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection von Starley, Brad Q., Calcagno, Christopher J., Harrison, Stephen A.

Volltext

The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials von Sanyal, Arun J., Harrison, Stephen A., Ratziu, Vlad, Abdelmalek, Manal F., Diehl, Anna Mae, Caldwell, Stephen, Shiffman, Mitchell L., Aguilar Schall, Raul, Jia, Catherine, McColgan, Bryan, Djedjos, C. Stephen, McHutchison, John G., Subramanian, G. Mani, Myers, Robert P., Younossi, Zobair, Muir, Andrew J., Afdhal, Nezam H., Bosch, Jaime, Goodman, Zachary

Volltext

Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States von Wong, Robert J, Aguilar, Maria, Cheung, Ramsey, Perumpail, Ryan B, Harrison, Stephen A, Younossi, Zobair M, Ahmed, Aijaz

Volltext

Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review von Ajmera, Veeral H., Terrault, Norah A., Harrison, Stephen A.

Volltext

Liver biopsy evaluation in MASH drug development: Think thrice, act wise von Harrison, Stephen A., Dubourg, Julie

Volltext